Target Name: F5
NCBI ID: G2153
Review Report on F5 Target / Biomarker Content of Review Report on F5 Target / Biomarker
F5
Other Name(s): Coagulation factor V heavy chain | PCCF | Activated protein c cofactor | coagulation factor V jinjiang A2 domain | Coagulation factor V jinjiang A2 domain | Factor V Leiden | Va | THPH2 | RPRGL1 | coagulation factor V | Factor V | Activated protein C cofactor | activated protein c cofactor | FA5_HUMAN | FV | coagulation factor V (proaccelerin, labile factor) | Coagulation factor V | Coagulation factor V light chain | factor V Leiden | Proaccelerin, labile factor | FVL | Factor Va

F5 Protein Plays A Critical Role in Body's Clotting Mechanism

F5 (Coagulation factor V heavy chain) is a protein that plays a critical role in the body's clotting mechanism. It is one of the five proteins that make up the coagulation cascade, which is a series of interactions between proteins that help to prevent blood clots from forming. F5 is a key player in this process, as it helps to activate the clotting cascade and enable blood clots to form.

F5 is a glycoprotein, which means that it consists of both protein and carbohydrate molecules. It is found in various tissues throughout the body, including the liver, spleen, and heart. It is also expressed in the blood, where it plays a vital role in the body's clotting mechanism.

F5 is a key component of the coagulation cascade because it helps to activate the clotting cascade. The coagulation cascade is a series of interactions between proteins that work together to prevent blood clots from forming. The cascade starts with the expression of F5, which activates the clotting cascade by helping to recruit additional proteins to the site of the clot.

Once F5 is recruited to the site of the clot, it helps to initiate the clotting cascade by interacting with the protein GPI (Glycophorin interacting protein). This interaction between F5 and GPI allows F5 to help recruit more proteins to the site of the clot, which in turn helps to form a blood clot.

F5 is also involved in the regulation of the clotting cascade. It helps to control the activity of other proteins that are involved in the clotting cascade, such as F2 (Coagulation factor II) and F3 (Coagulation factor III). This allows it to play a more precise role in the body's clotting mechanism.

F5 is a potential drug target for researchers because it is involved in the regulation of the body's clotting mechanism. By targeting F5 with drugs, researchers may be able to prevent blood clots from forming, which could be useful in the treatment of a variety of conditions, such as heart disease, stroke, and deep vein thrombosis.

In addition to its role in the clotting cascade, F5 is also a potential biomarker for the diagnosis of certain conditions. For example, individuals with genetic disorders that affect the body's clotting mechanism may have reduced levels of F5 in their blood. This could make it an useful diagnostic tool for these conditions.

Overall, F5 is a protein that plays a critical role in the body's clotting mechanism. It is a key player in the coagulation cascade and is involved in the regulation of the clotting cascade. As a result, it is an attractive target for drug research and may also be an useful biomarker for the diagnosis of certain conditions.

Protein Name: Coagulation Factor V

Functions: Central regulator of hemostasis. It serves as a critical cofactor for the prothrombinase activity of factor Xa that results in the activation of prothrombin to thrombin

The "F5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about F5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

F7 | F8 | F8A1 | F8A2 | F8A3 | F9 | FA2H | FAAH | FAAH2 | FAAHP1 | FAAP100 | FAAP20 | FAAP24 | FABP1 | FABP12 | FABP2 | FABP3 | FABP4 | FABP5 | FABP5P1 | FABP5P10 | FABP5P11 | FABP5P2 | FABP5P3 | FABP5P7 | FABP6 | FABP7 | FABP7P1 | FABP9 | FACT complex | FADD | FADS1 | FADS2 | FADS2B | FADS3 | FADS6 | FAF1 | FAF2 | FAH | FAHD1 | FAHD2A | FAHD2B | FAHD2CP | FAIM | FAIM2 | FALEC | FAM104A | FAM104B | FAM106A | FAM106C | FAM107A | FAM107B | FAM110A | FAM110B | FAM110C | FAM110D | FAM111A | FAM111A-DT | FAM111B | FAM114A1 | FAM114A2 | FAM117A | FAM117B | FAM118A | FAM118B | FAM120A | FAM120A2P | FAM120AOS | FAM120B | FAM120C | FAM124A | FAM124B | FAM131A | FAM131B | FAM131B-AS2 | FAM131C | FAM133A | FAM133B | FAM133CP | FAM133DP | FAM135A | FAM135B | FAM136A | FAM136BP | FAM138A | FAM138B | FAM138C | FAM138D | FAM138F | FAM13A | FAM13A-AS1 | FAM13B | FAM13C | FAM149A | FAM149B1 | FAM151A | FAM151B | FAM153A | FAM153B | FAM153CP